A Dedicated Oligonucleotide Analysis System
Get information on your synthetic Oligos & Aptamers
- Molecular weight and purity of synthetic oligos and aptamers
- Quality control after synthesis or purification
- Choice of short and long gradient methods
- Ion pair mobile phases provided
Synthetic Oligonucleotide Therapies | Agilent
For workflow related questions, please contact Richard Blankley (Agilent) or Kamil Skirlo (ICL)